Eton Pharmaceuticals, Inc. drugs

4 results
  • alkindi

    (Hydrocortisone)
    Eton Pharmaceuticals, Inc.
    ALKINDI SPRINKLE is indicated for use as replacement therapy in pediatric patients diagnosed with adrenocortical insufficiency.
  • carglumic acid

    (Carglumic Acid)
    Eton Pharmaceuticals, Inc.
    Carglumic acid tablets are indicated for adults and pediatric patients as adjunctive therapy for acute hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency and for maintenance treatment of chronic hyperammonemia due to the same condition.
  • galzin

    (Zinc Acetate)
    Eton Pharmaceuticals, Inc.
    Zinc acetate is indicated for the maintenance treatment of patients with Wilson’s disease who have previously received initial therapy with a chelating agent.
  • khindivi

    (Hydrocortisone)
    Eton Pharmaceuticals, Inc.
    KHINDIVI is indicated for replacement therapy in pediatric patients aged 5 and older with adrenocortical insufficiency. It is not approved for increased dosing during stress or acute events; alternative hydrocortisone-containing products should be used for those situations.